Gene · 3108
Papers2,126
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,126
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles. | PLoS Negl Trop Dis | 2023 | 36696438 | PubTator, text mining | PubMed |
| Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy. | Nat Cancer | 2023 | 36690875 | PubTator, text mining | PubMed |
| Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. | Pediatr Blood Cancer | 2023 | 36683202 | PubTator, text mining | PubMed |
| Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 36674951 | PubTator, text mining | PubMed |
| A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3. | Int J Mol Sci | 2023 | 36674743 | PubTator, text mining | PubMed |
| ADGR: Admixture-Informed Differential Gene Regulation. | Genes (Basel) | 2023 | 36672888 | PubTator, text mining | PubMed |
| Advances in Molecular Pathophysiology and Targeted Therapy for Cushing's Disease. | Cancers (Basel) | 2023 | 36672445 | PubTator, text mining | PubMed |
| Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer. | Cancers (Basel) | 2023 | 36672336 | PubTator, text mining | PubMed |
| MHC Class II Presentation in Autoimmunity. | Cells | 2023 | 36672249 | PubTator, text mining | PubMed |
| Sequencing-based fine-mapping and in silico functional characterization of the 10q24.32 arsenic metabolism efficiency locus across multiple arsenic-exposed populations. | PLoS Genet | 2023 | 36668670 | PubTator, text mining | PubMed |
| Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy. | Sci Rep | 2023 | 36653470 | PubTator, text mining | PubMed |
| Yeast display platform with expression of linear peptide epitopes for high-throughput assessment of peptide-MHC-II binding. | J Biol Chem | 2023 | 36649909 | PubTator, text mining | PubMed |
Single-cell RNA sequencing reveals transcriptional changes of human choroidal and retinal pigment epithelium cells during fetal development, in healthy adult and intermediate age-related macular degeneration. | Hum Mol Genet | 2023 | 36645183 | PubTator, text mining | PubMed |
| M6PR- and EphB4-Rich Exosomes Secreted by Serglycin-Overexpressing Esophageal Cancer Cells Promote Cancer Progression. | Int J Biol Sci | 2023 | 36632458 | PubTator, text mining | PubMed |
| Genetic landscape and immune mechanism of monocytes associated with the progression of acute-on-chronic liver failure. | Hepatol Int | 2023 | 36626090 | PubTator, text mining | PubMed |
| Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development. | Life Sci | 2023 | 36621539 | PubTator, text mining | PubMed |
| Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. | Cells | 2023 | 36611973 | PubTator, text mining | PubMed |
| T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. | Nat Med | 2023 | 36604540 | PubTator, text mining | PubMed |
| An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. | Nat Cancer | 2023 | 36581735 | PubTator, text mining | PubMed |
| Targeted capture enrichment and sequencing identifies HLA variants associated with the severity of COVID-19. | Genes Genomics | 2023 | 36574143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3108/papers?page=14